查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387357

抗高血压药物市场报告：2030 年趋势、预测与竞争分析

Antihypertensive Drug Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

抗高血压药物趋势与预测

预计2024年至2030年全球抗高血压药物市场将以4.7%的复合年增长率成长。这个市场的主要驱动因素是高血压盛行率的增加、私人和政府机构的配合措施和倡议的增加以及人们对高血压的认识不断提高。全球降血压药市场前景广阔，零售药局、医院药局、电商市场都有商机。

抗高血压药物市场洞察

Lucintel 预测，与其他疗法相比，钙通道拮抗由于其价格实惠、疗效更高且副作用更少，预计在预测期内仍将是最大的细分市场。

由于全球医院数量不断增加，医院仍然是该市场中最大的部分。

由于高血压盛行率迅速上升和老年人口不断增加，北美在预测期内可能仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3. 您认为哪个地区的成长速度会更快？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5.市场上的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球抗高血压药物市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球抗高血压药物市场趋势（2018-2023）与预测（2024-2030）
  • 按治疗药物类别分類的全球抗高血压药物市场
    • 利尿剂
    • ACE抑制剂
    • 钙拮抗
    • 血管扩张剂
    • β-肾上腺素阻断剂
    • 其他的
  • 按配销通路的全球抗高血压药物市场
    • 零售药房
    • 医院药房
    • 电子商务
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球抗高血压药物市场区域分布
  • 北美降血压药市场
  • 欧洲抗高血压药物市场
  • 亚太地区抗高血压药物市场
  • 其他地区降血压药市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按治疗药物类别分類的全球抗高血压药物市场成长机会
    • 全球抗高血压药物市场成长机会（按配销通路）
    • 全球抗高血压药物市场按地区成长机会
  • 全球抗高血压药物市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球抗高血压药物市场的产能扩张
    • 全球抗高血压药物市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • AstraZeneca
  • Novartis
  • SANOFI
  • Merck
简介目录

Antihypertensive Drug Trends and Forecast

The future of the global antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets. The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

A more than 150-page report is developed to help in your business decisions.

Antihypertensive Drug by Segment

The study includes a forecast for the global antihypertensive drug by therapeutic class, distribution channel, and region.

Antihypertensive Drug Market by Therapeutic Class [Shipment Analysis by Value from 2018 to 2030]:

  • Diuretics
  • ACE Inhibitors
  • Calcium Channel Blockers
  • Vasodilators
  • Beta-Adrenergic Blockers
  • Others

Antihypertensive Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-Commerce
  • Others

Antihypertensive Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Antihypertensive Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antihypertensive drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antihypertensive drug companies profiled in this report include-

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • Astrazeneca
  • Novartis
  • SANOFI
  • Merck

Antihypertensive Drug Market Insights

Lucintel forecasts that calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.

Within this market, hospital will remain the largest segment due to increase in number of hospitals worldwide.

North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Features of the Global Antihypertensive Drug Market

Market Size Estimates: Antihypertensive drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Antihypertensive drug market size by therapeutic class, distribution channel, and region in terms of value ($B).

Regional Analysis: Antihypertensive drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutic classes, distribution channels, and regions for the antihypertensive drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antihypertensive drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for antihypertensive drug market?

Answer: The global antihypertensive drug market is expected to grow with a CAGR of 4.7% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the antihypertensive drug market?

Answer: The major drivers for this market are growing incidence of hypertension, rising efforts and initiatives by both private and government organizations, and increasing awareness of hypertension.

Q3. What are the major segments for antihypertensive drug market?

Answer: The future of the antihypertensive drug market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and e-commerce markets.

Q4. Who are the key antihypertensive drug market companies?

Answer: Some of the key antihypertensive drug companies are as follows:

  • Lupin
  • Boehringer Ingelheim International
  • Sun PharmACEutical Industries
  • Astrazeneca
  • Novartis
  • SANOFI
  • Merck

Q5. Which antihypertensive drug market segment will be the largest in future?

Answer: Lucintel forecasts that calcium channel blocker will remain the largest segment over the forecast period due to its affordability, high efficacy, and lesser side effects as compare to other therapeutic classes.

Q6. In antihypertensive drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in incidence of hypertension and rise in geriatric population.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the antihypertensive drug market by therapeutic class (diuretics, ACE inhibitors, calcium channel blockers, vasodilators, beta-adrenergic blockers, and others), distribution channel (retail pharmacy, hospital pharmacy, e-commerce, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pACE and why?
  • Q.3. Which region will grow at a faster pACE and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Antihypertensive Drug Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Antihypertensive Drug Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Antihypertensive Drug Market by Therapeutic Class
    • 3.3.1: Diuretics
    • 3.3.2: ACE Inhibitors
    • 3.3.3: Calcium Channel Blockers
    • 3.3.4: Vasodilators
    • 3.3.5: Beta-adrenergic Blockers
    • 3.3.6: Others
  • 3.4: Global Antihypertensive Drug Market by Distribution Channel
    • 3.4.1: Retail Pharmacy
    • 3.4.2: Hospital Pharmacy
    • 3.4.3: E-commerce
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Antihypertensive Drug Market by Region
  • 4.2: North American Antihypertensive Drug Market
    • 4.2.2: North American Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.3: European Antihypertensive Drug Market
    • 4.3.1: European Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.3.2: European Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.4: APAC Antihypertensive Drug Market
    • 4.4.1: APAC Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.4.2: APAC Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others
  • 4.5: ROW Antihypertensive Drug Market
    • 4.5.1: ROW Antihypertensive Drug Market by Therapeutic Class: Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others
    • 4.5.2: ROW Antihypertensive Drug Market by Distribution Channel: Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Antihypertensive Drug Market by Therapeutic Class
    • 6.1.2: Growth Opportunities for the Global Antihypertensive Drug Market by Distribution Channel
    • 6.1.3: Growth Opportunities for the Global Antihypertensive Drug Market by Region
  • 6.2: Emerging Trends in the Global Antihypertensive Drug Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Antihypertensive Drug Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antihypertensive Drug Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Lupin
  • 7.2: Boehringer Ingelheim International
  • 7.3: Sun PharmACEutical Industries
  • 7.4: AstraZeneca
  • 7.5: Novartis
  • 7.6: SANOFI
  • 7.7: Merck